Steady-state Pharmacokinetics of Phenytoin from Routinely Collected Patient Data

SummaryPreviously reported routine Phenytoin clinical pharmacokinetic data from Japan, England, and Germany were analysed to estimate population pharmacokinetic parameters. There were 780 steady-state phenytoin concentrations and associated dosage rates (mg/day) from 322 patients. The patient group spanned paediatric and adult ages, mean age being 18.4 ± 17.3 (SD) years; 53% were males. The data were analysed using NONMEM, a computer programme designed for population pharmacokinetic analysis. Estimates of the influence of age, gender, data source, height and weight on the maximum elimination rate (Vm) and Michaelis-Menten constant (Km) were obtained. The Vm and Km of a 70kg adult male European were estimated to be 415 mg/day and 5.7 mg/L, respectively. Vm is not influenced by gender, age or data source. The parameters of a power function of height and weight were estimated to adjust Vm for body size. The best function adjusts Vm in proportion to weight to the 0.6 power; height contains no useful information.Km is not influenced by gender. The Km for patients less than 15 years old is 43% less than that of older patients. The Km of Japanese patients appears to be 23% less than that for European patients.Even after adjustments for age, etc., apparent Vm and Km vary unpredictably among individuals with a coefficient of variation between 10 to 20%, and approximately 50% respectively.

[1]  L. Sheiner,et al.  Instructional goals for physicians in the use of blood level data—and the contribution of computers , 1974, Clinical pharmacology and therapeutics.

[2]  W. Kalow,et al.  Ethnic Differences in Drug Metabolism , 1982, Clinical pharmacokinetics.

[3]  Peter W. Mullen,et al.  Optimal phenytoin therapy: A new technique for individualizing dosage , 1978, Clinical pharmacology and therapy.

[4]  M D Rawlins,et al.  Pharmacokinetics of phenytoin in children. , 1981, British journal of clinical pharmacology.

[5]  D. D. Bois,et al.  CLINICAL CALORIMETRY: TENTH PAPER A FORMULA TO ESTIMATE THE APPROXIMATE SURFACE AREA IF HEIGHT AND WEIGHT BE KNOWN , 1916 .

[6]  M. McCarron,et al.  Clinical Pharmacy CASE Studies , 1974 .

[7]  T Ishizaki,et al.  Michaelis-Menten pharmacokinetics of diphenylhydantoin and application in the pediatric age patient. , 1980, The Journal of pediatrics.

[8]  A. Richens,et al.  Predicting Phenytoin Dose—A Revised Nomogram , 1979, Therapeutic drug monitoring.

[9]  F. Buchthal,et al.  DIPHENYLHYDANTOIN AND PHENOBARBITAL. SERUM LEVELS IN CHILDREN. , 1964, American journal of diseases of children.

[10]  F. N. David,et al.  LINEAR STATISTICAL INFERENCE AND ITS APPLICATION , 1967 .

[11]  A. Richens,et al.  SERUM-PHENYTOIN LEVELS IN MANAGEMENT OF EPILEPSY , 1975, The Lancet.

[12]  Calyampudi Radhakrishna Rao,et al.  Linear Statistical Inference and its Applications , 1967 .

[13]  K Schmidt-Nielsen,et al.  Energy metabolism, body size, and problems of scaling. , 1970, Federation proceedings.

[14]  G. Redmond,et al.  Effect of human growth hormone on amobarbital metabolism in children , 1978, Clinical pharmacology and therapeutics.

[15]  K. Dawson,et al.  Value of blood phenytoin estimation in management of childhood epilepsy. , 1971, Archives of disease in childhood.

[16]  K. Korttila,et al.  Diazepam effects and kinetics in Caucasians and Orientals , 1981, Clinical pharmacology and therapeutics.

[17]  M. McCarron,et al.  Clinical Pharmacy: Case Studies , 1974 .

[18]  D. DuBois,et al.  A formula to estimate the approximate surface area if height and weight be known , 1989 .

[19]  A. Richens,et al.  Effect of age, height, weight and sex on serum phenytoin concentration in epileptic patients. , 1975, British journal of clinical pharmacology.

[20]  T. Ludden,et al.  Individualization of phenytoin dosage regimens , 1977, Clinical pharmacology and therapeutics.